Predicting the Public Health Impact of Bivalent Vaccines and Nirmatrelvir-Ritonavir Against Coronavirus Disease 2019

BACKGROUND: Uptake of coronavirus disease 2019 (COVID-19) bivalent vaccines and the oral medication nirmatrelvir-ritonavir (Paxlovid) has remained low across the United States. Assessing the public health impact of increasing uptake of these interventions in key risk groups can guide further public...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hailey J, Tan, Sophia T, León, Tomás M, Jain, Seema, Schechter, Robert, Lo, Nathan C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478155/
https://www.ncbi.nlm.nih.gov/pubmed/37674629
http://dx.doi.org/10.1093/ofid/ofad415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478155/
https://www.ncbi.nlm.nih.gov/pubmed/37674629
http://dx.doi.org/10.1093/ofid/ofad415

Ejemplares similares